Axial Spondyloarthritis
Socioeconomic Impact and Prognosis
Incidence and Prevalence
Classification Criteria
Axial Spondyloarthritis and Ankylosing Spondylitis
Imaging
Etiology and Pathogenesis
Long-term exercise program improves physical function in axial SpA beyond ‘usual care’
A long-term, supervised exercise program for patients with axial spondyloarthritis and severe functional limitations improved functional disability and physical quality of life vs. usual care, according to data published in Rheumatology.
Patients with rheumatoid arthritis, PsA, AS ‘stuck in a cycle of long-term opioid use’
Patients with rheumatic diseases demonstrate a high reliance on opioids around the time of diagnosis, and significant numbers of patients were not on appropriate treatment in the year afterward, according to data in Clinical Rheumatology.
TNF inhibitor efficacy in axial spondyloarthritis varies greatly by sex via BASDAI score
The effectiveness of TNF inhibitors for axial spondyloarthritis varies significantly between men and women based on BASDAI score, but not ASDAS, according to data published in Arthritis Research & Therapy.
Discontinuing biologics in axial spondyloarthritis 'not a good idea'
DESTIN, Fla. — New data on discontinuation or dose reduction of biologic therapies has led to a shifting landscape in axial spondyloarthritis management, according to a speaker at the Congress of Clinical Rheumatology East annual meeting.